$BMY

BULLISH2022-09-12

By horizon✗ miss-2.8%

✓ +1.6%

…

21d

✗ -2.8%

Original post

Andy Biotech · 2022-09-12

#ESMO22 $AMGN Lumakras very underwhelming Codebreak-200 data on top of an already slow launch How to justify $18K/mo price w/ ~1mo mPFS benefit and detrimental overall survival? Double whammy day w/ $BMY Sotyktu clean label re. Otezla. Silver lining: more need for SMID bio M&A? https://t.co/yUJzraVg36

View on X ↗